Greenphire, a King of Prussia medical travel provider, is expanding the global reach of its ability to transport patients to sites offering clinical trials for illness. Benzinga Financial News & Data reported the newly invigorated program.

The Greenphire service, branded as ConneX, not only helps patients directly, it aids them indirectly by ensuring that global study retention goals are met. The metric is an important evaluator, enabling results tracking for the same cluster of participants over time.

The Center for Information & Study on Clinical Research Participation and the Tufts Center for the Study of Drug Development, both in Boston, highlight the importance of travel support for patients in clinical trials.

The ConneX capability provides concierge-like services covering:

• Air and train travel
• Hotel accommodations
• Car services and rideshares
• Ambulatory care
• Visa support

The company is bolstering its assistance primarily for international patients in Japan, Central and Southern Europe, Scandinavia, and Southeast Asia.

More on Greenphire and ConneX is at Benzinga Financial News & Data.

_____

Clinical trials are vastly important to the healthcare industry, making the removal of barriers in accessing them a worthy goal.